- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05749198
Portal Hypertension Using Magnetic Resonance Elastography
February 28, 2023 updated by: Moon Young Kim, Yonsei University
Non-invasive Assessment of Portal Hypertension Using Quantitative Magnetic Resonance Imaging
This prospective study was conducted in a tertiary university hospital.
The investigators researched the correlation between MRE-assessed stiffness of the liver and spleen and the Hepatic venous pressure gradient (HVPG) values.
Furthermore, the investigator evaluated whether MRE-assessed stiffness reflected changes in portal hypertension (PH) after administering non-selective beta-blockers (NSBBs).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
47
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gangwon
-
Wŏnju, Gangwon, Korea, Republic of, 22070
- WonJu Severance Christian Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients requiring prophylactic treatment of esophageal varices
Description
Inclusion Criteria:
- diagnosed liver cirrhosis
- requiring prophylactic treatment of esophageal varices
Exclusion Criteria:
- the coexistence of hepatocellular carcinoma
- refractory ascites who regularly underwent large-volume paracentesis
- the use of selective beta-blocker or carvedilol therapy for at least 4 weeks
- undergoing liver transplantation
- contraindication with magnetic resonance imaging
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change of liver stiffness and spleen stiffness by MRE
Time Frame: Change from baseline stiffness of MRE at 6 months
|
Change from baseline stiffness of MRE at 6 months
|
|
The change of portal pressure (HVPG) prior to and after treatment with NSBB
Time Frame: Change from baseline and at 6 months
|
Change from baseline and at 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 2, 2018
Primary Completion (Actual)
September 30, 2019
Study Completion (Actual)
January 28, 2023
Study Registration Dates
First Submitted
February 14, 2023
First Submitted That Met QC Criteria
February 28, 2023
First Posted (Actual)
March 1, 2023
Study Record Updates
Last Update Posted (Actual)
March 1, 2023
Last Update Submitted That Met QC Criteria
February 28, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR317132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Magnetic Resonance Imaging
-
BayerCompletedMagnetic Resonance Imaging | Magnetic Resonance AngiographyPoland, China, France, Germany, Hungary, Korea, Republic of, South Africa, Spain, Thailand, Taiwan, Czech Republic, Hong Kong, Italy, Kazakhstan, Russian Federation, Bosnia and Herzegovina, Greece, Canada, Vietnam, Kyrgyzstan
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingMagnetic Resonance ImagingFrance
-
Centre Hospitalier Universitaire, AmiensCompletedMagnetic Resonance ImagingFrance
-
Jessa HospitalCompletedMagnetic Resonance ImagingBelgium
-
BayerCompletedMagnetic Resonance ImagingUnited States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
-
Boston Scientific CorporationCompletedMagnetic Resonance ImagingSpain, Hong Kong, Germany, Israel, United Kingdom, Italy, United States, Malaysia, Belgium
-
MegaPro Biomedical Co. Ltd.CompletedMagnetic Resonance ImagingTaiwan
-
BayerCompletedMagnetic Resonance ImagingJapan
-
BayerCompletedMagnetic Resonance ImagingPhilippines
-
BayerCompletedMagnetic Resonance Imaging | Myocardial Perfusion ImagingSwitzerland, Germany, Austria, Poland
Clinical Trials on MRE
-
Shengjing HospitalRecruitingCirrhosis | Liver Portal HypertensionChina
-
United States Army Research Institute of Environmental...Completed
-
University Hospital, BordeauxCompletedInterstitial Fibrosis/Tubular Atrophy of Transplanted KidneysFrance
-
University College, LondonRecruiting
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...RecruitingCrohn DiseaseBelgium, France
-
Shaare Zedek Medical CenterThe Hospital for Sick Children; Rambam Health Care Campus; Children's Hospital... and other collaboratorsCompleted
-
GLSMED Learning Health S.A.AbbVieRecruitingCrohn DiseaseSpain, Italy, United Kingdom, Denmark, Cyprus, Czechia, Malta, Portugal, Belgium, France, Romania
-
Dartmouth-Hitchcock Medical CenterNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Active, not recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnBrain NeoplasmUnited States
-
University College, LondonBritish Society of Gastrointestinal and Abdominal Radiology (BSGAR)Recruiting